Kuo Jiang

CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner

Qian‐Feng Zhang, Jia Li, Kuo Jiang et al. · Theranostics · 2020 · 199 citations · Full text

Medicine, Immunology, Oncology +17

SDF-1/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy

Kuo Jiang, Jia Li, Jitao Zhang et al. · International Immunopharmacology · 2019 · 102 citations · Full text

Medicine, Immunology, Oncology +17

Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer

Jia Li, Kuo Jiang, Xiuchun Qiu et al. · BMB Reports · 2014 · 63 citations · Full text

Medicine, Cancer Biology, Oncology +16

Estrogen enhances the proliferation and migration of ovarian cancer cells by activating transient receptor potential channel C3

Shengnan Li, Kuo Jiang, Jia Li et al. · Journal of Ovarian Research · 2020 · 57 citations · Full text

Medicine, Endocrinology, Oncology +11

Targeted delivery of CXCR4-siRNA by scFv for HER2+ breast cancer therapy

Kuo Jiang, Jia Li, Jipeng Yin et al. · Biomaterials · 2015 · 44 citations

Pharmacy, Oncology, Pharmaceutics +12